Malta - English - Medicines Authority

baxter healthcare limited - human fibrinogen; aprotinin; human thrombin; calcium chloride dihydrate - solution for sealant - human fibrinogen 182 mg; aprotinin 6000 kiu/ml; human thrombin 1000 iu; calcium chloride dihydrate 80 µmol - antihemorrhagics

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, aprotinin, fibrinogen, human, thrombin - solution for sealant - calcium chloride 40 µmole/ml aprotinin 3000 kiu/ml fibrinogen, human 91 mg/ml thrombin, human 500 iu/mg - antihemorrhagics

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - human fibrinogen, aprotinin, human thrombin, calcium chloride, dihydrate - solution for sealant - human fibrinogen 182 mg aprotinin 6000 kiu/ml human thrombin 1000 iu calcium chloride dihydrate 80 µmol - antihemorrhagics

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - human fibrinogen, aprotinin, human thrombin, calcium chloride, dihydrate - solution for sealant - human fibrinogen 455 mg aprotinin 1500 kiu/ml human thrombin 2500 iu calcium chloride dihydrate 200 mmol - antihemorrhagics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - aprotinin; thrombin; calcium chloride; fibrinogen - solution for sealant - 3000kallikrein inactivator unit/1ml ; 500unit/1ml ; 40micromol/1ml ; 91mg/1ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dy-mark (aust.) pty. ltd. - liquid hydrocarbon - topical aerosol spray - liquid hydrocarbon solvent other 523.0 g/kg - miscellaneous veterinary - stock - dye marker

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (apl), french-american-british (fab) classification m3 (including the m3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the pml/rarα gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline based chemotherapy is contraindicated. tretinoin is for the induction of remission only. the optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for apl after completion of induction therapy with tretinoin. tretinoin is contraindicated in patients with a known hypersensitivity to tretinoin, any of its components, or other retinoids.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - tretinoin 10 mg - tretinoin capsules are indicated for the induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (apl) characterized by the presence of the t(15;17) translocation or pml/rarα gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated. tretinoin capsules are contraindicated in patients with a known hypersensitivity to tretinoin, any of its components, or other retinoids. reactions have included rash, pruritus, face edema, and dyspnea. [see adverse reactions (6.1)] . risk summary based on findings in animals and its mechanism of action [see clinical pharmacology (12.1)] , tretinoin can cause embryo-fetal loss and malformations when administered to a pregnant woman. tretinoin is a retinoid and there is an increased risk of major congenital malformations, spontaneous abortions and premature births following exposure to retinoids during pregnancy in human

Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals limited - bifidobacterium animalis ssp lactis,bifidobacterium bifidum,lactobacillus fermentum,lactobacillus gasseri,lactobacillus plantarum,lactobacillus rhamnosus,lactobacillus salivarius ssp salivarius -

Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals limited - bifidobacterium animalis ssp lactis,bifidobacterium bifidum,lactobacillus acidophilus -